相关实验视频
Updated: Feb 25, 2026

06:30
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
1.0K
工程眼科纳米乳液平台:在眼部药物输送中的设计原理和翻译应用.
Vijay R Mahajan1, Yuvraj P Kokane1, Arshad S Shaikh2
1Department of Pharmaceutics, SMBT College of Pharmacy, Nandihills, Nashik, India.
概括
纳米乳液为眼部药物输送挑战提供了一个有希望的解决方案,例如透率差. 这些系统提高了药物的溶解性和稳定性,克服了生理障碍,使眼睛治疗更有效.
科学领域:
- 制药科学 制药科学
- 生物技术是生物技术.
- 材料科学 材料科学 材料科学
背景情况:
- 传统的眼部药物输送面临着重大挑战,原因是生理因素,如快速的眼周转率和较差的角膜透.
- 这些局限性导致前角膜停留时间短,药物的生物可用性降低,阻碍了有效的眼科治疗.
研究的目的:
- 审查纳米乳液策略作为一种有前途的方法,以克服传统的眼部药物输送限制.
- 讨论眼睛纳米乳液的设计原理,配方组件,制造方法和稳定性.
主要方法:
- 对用于眼部输送的纳米乳液配方应用的工程原理的审查.
- 讨论各种高能生产方法,包括自发乳化,超声波和高压均质化.
- 探索刺激敏感,粘膜粘合和正电荷纳米乳液的最新进展.
主要成果:
- 纳米乳液的粒子直径小于200纳米,可改善药物溶解度,眼部生物可用性和配方稳定性.
- 各种制造技术适合生产眼睛纳米乳液,正在研究新型系统类型.
- 尽管有优势,但与长期稳定性,生产复杂性和成本相关的挑战仍然存在.
结论:
- 眼部纳米乳液输送系统代表了一种可行的和灵活的战略,以提高眼部药物输送.
- 定制的纳米乳液配方具有很大的潜力,可以克服眼科药物管理中的现有挑战.
相关概念视频
Ophthalmic Drug Delivery Systems
77
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
77
Site-Targeted Drug Delivery Systems: Polymeric Carriers
57
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
57
Modified-Release Drug Delivery Systems: Overview
53
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
53
Drug Delivery: Overview
997
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
997
Drug Delivery Systems: Different Types
64
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
64
Oral Drug Delivery Systems: Introduction
69
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
69

